Fiorentino, F. and Di Rienzo, P. 2023. Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy. Global and Regional Health Technology Assessment. 10, 1 (Apr. 2023), 29–39. DOI:https://doi.org/10.33393/grhta.2023.2507.